NCT05194007View on ClinicalTrials.gov

Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 19, 2022

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2024

Conditions
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic ModerateCrohn Colitis
Interventions
DRUG

Frondanol

Frondanol capsule (1000 mg) will be administered orally (Twice daily) in the double blind settings

DRUG

Placebo

Placebo (corn starch) capsule will be administered orally (Twice daily) in the double blind settings

Trial Locations (2)

Unknown

Mediclinic City Hospital, Dubai

Mediclinic Parkview Hospital, Dubai

All Listed Sponsors
collaborator

Mediclinic Middle East

INDUSTRY

collaborator

Rashid Hospital

OTHER_GOV

collaborator

Dubai Health Authority

OTHER_GOV

lead

Mohammed Bin Rashid University of Medicine and Health Sciences

OTHER